The company announced that it will start the production of the hypoallergenic milk EleCare and other baby milks and their distribution will start around June 20.
The American company Abbott Laboratories announced today that it has reopened its factory that produces baby milk in Sturgess, Michigan – a step towards alleviating the acute shortage of baby milk in the country.
The company announced that it will start the production of the hypoallergenic milk EleCare and other baby milks and their distribution will start around June 20.
The US Food and Drug Administration (FDA) announced on May 19 that the plant could open in a week or two.
The facility now meets the requirements agreed with the FDA under the Abbott deal with the federal agency on May 16, the company said.
The closure of the factory and the withdrawal of baby milk have exacerbated the shortage in a country where, according to federal figures from 2020, less than half of babies are exclusively breastfed for the first three months of life.
Abbott began recalling its products in February, following reports of bacterial infections in children who had consumed factory-made infant milk.
The FDA inspection at the Sturgess facility had “shocking” results, as cracks in vital equipment were identified, as well as serious hygiene problems.
The FDA then agreed with Abbott to oversee the company’s efforts to rectify the plant’s problems.
